Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.37 |
| ▸ | GAA | P10253 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | DHODH | Q02127 | 1/20 | 0.36 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.36 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | CDC25A | P30304 | 1/20 | 0.34 |
| ▸ | CDC25B | P30305 | 1/20 | 0.34 |
| ▸ | CDC25C | P30307 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4110223 | 0.88 | SMN1; SMN2 (0.42) | SMN1; SMN2L3MBTL1TSHRMEN1KMT2A | |
| SCHEMBL4110227 | 0.88 | SMN1; SMN2 (0.42) | SMN1; SMN2L3MBTL1TSHRMEN1KMT2A | |
| SCHEMBL4130779 | 0.88 | MPO (0.46) | SMN1; SMN2L3MBTL1TSHRMEN1KMT2A | |
| SCHEMBL4110253 | 0.85 | GAA (0.43) | SMN1; SMN2L3MBTL1TSHRMEN1KMT2A | |
| SCHEMBL4110251 | 0.85 | GAA (0.43) | SMN1; SMN2L3MBTL1TSHRMEN1KMT2A | |
| SCHEMBL5069854 | 0.84 | HTR2A (0.38) | SMN1; SMN2KMT2AALDH1A1LMNAHTR2A | |
| SCHEMBL5069856 | 0.84 | HTR2A (0.38) | SMN1; SMN2KMT2AALDH1A1LMNAHTR2A | |
| SCHEMBL4122756 | 0.83 | TSHR (0.42) | SMN1; SMN2L3MBTL1TSHRMEN1KMT2A | |
| SCHEMBL4122757 | 0.83 | TSHR (0.42) | SMN1; SMN2L3MBTL1TSHRMEN1KMT2A | |
| SCHEMBL4122272 | 0.78 | SMN1; SMN2 (0.42) | SMN1; SMN2TSHRMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8258302-B2 | Method for producing benzazepinone | API CORPORATION (JP) | 2012-09-04 | — | — | US | disclosed |
| US-20090171090-A1 | METHOD FOR PRODUCING BENZAZEPINONE | API CORPORATION (JP) | 2009-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090171090-A1 | METHOD FOR PRODUCING BENZAZEPINONE | NISCH, GABBR1, GABBR2 | SMN1; SMN2 3973/4885L3MBTL1 4853/4885TSHR 3834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.